Pharma Channel Preference Survey
Understand how pharmacists, stockists, hospitals, and prescribing stakeholders evaluate manufacturer access, compare supply partners, and choose engagement channels, so you can sharpen channel strategy, improve account acquisition, and strengthen portfolio positioning across priority pharmaceutical markets.
CONTEXT & RELEVANCE
Why run this survey now
Most pharma brands don't lose channel preference purely on price. They underperform due to inconsistent service, weak field engagement, stock availability gaps, margin dissatisfaction, and support gaps, none of which show up in sales reports or distributor reviews.
If you are...
- Pharma commercial strategy leaders
- Trade marketing and activation teams
- Sales excellence and field leaders
- Distribution and supply heads
RESEARCH THEMES
What This Survey Investigates
Eight interconnected research themes that map the complete pharma channel journey from awareness to sustained preference.
Awareness & Reach
- Manufacturer awareness sources
- Territory reach consistency
Access & Availability
- Stock availability reliability
- Credit access conditions
Service & Fulfilment
- Order fulfilment quality
- Issue resolution responsiveness
Margins & Terms
- Margin attractiveness benchmarks
- Scheme fairness perceptions
Field Force Engagement
- Representative interaction quality
- Scientific support usefulness
Digital Channel Use
- Ordering platform adoption
- Digital support preferences
Brand & Portfolio
- Portfolio relevance perceptions
- Manufacturer credibility signals
Loyalty & Switching
- Partner loyalty strength
- Switching trigger hierarchy
SAMPLING STRATEGY
Tell us about your ideal sample
Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.
METHODOLOGY
Survey approach
For Pharma Channel Preference Survey, we recommend a segmented multi-stakeholder approach with flexible data-collection modes to balance reach, depth, and verification across distributors, stockists, pharmacists, hospital buyers, and chain pharmacy managers.
EXECUTION PROCESS
How we execute
A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.
Define the decision frame
Confirm objectives, target cohorts, geographies, and reporting cuts
Define the decision frame
Design the instrument
Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)
Design the instrument
Lock the questionnaire
Review wording, sequencing, LOI, and competitive context; approve final version
Lock the questionnaire
Pilot and calibrate
Test comprehension and ease quality; refine quotas and remove friction where needed
Pilot and calibrate
Run fieldwork
Execute collection with active quota management and feasibility controls
Run fieldwork
Assure quality
Dedupe, attention checks, speed/consistency rules, removals with audit trail
Assure quality
Prepare the dataset
Clean data and deliver codebook/variable definitions
Prepare the dataset
Analyse and synthesise
Driver ranking, leakage diagnostics, pricing bands, segment insights
Analyse and synthesise
Deliver and align
Executive deck (optional dashboard) and leadership readout with recommendations
Deliver and align
COMMERCIAL TERMS
Request a Commercial Proposal
Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.
Select Sample Size
Geography
Select Mode of Survey
Length of the Interview
$0.00
+ applicable taxes
Cost Breakdown
Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.
REFERENCE CASELETS
Reference
Real-world examples of survey work in the pharmaceutical distribution and trade space.
Trade Promotion Effectiveness Benchmarking Across Prescription Brands (India)
OBJECTIVE
WHAT WE DID
DELIVERED
Trade Promotion Effectiveness Benchmarking Across Prescription Brands (India)
Hospital Formulary Access Barriers for Specialty Therapies (India)
Trade Promotion Effectiveness Benchmarking Across Prescription Brands (India)
OBJECTIVE
A pan-India manufacturer needed to understand how retail pharmacists , stockists , and independent distributors noticed, valued, and acted on competing trade promotions across acute and chronic therapy portfolios before redesigning its activation calendar.
WHAT WE DID
We ran a structured survey with 720 channel respondents across 18 cities, capturing promotion recall , scheme participation , communication source, redemption ease, perceived fairness, and differences by outlet scale, therapy mix, and relationship tenure.
DELIVERED
The study produced a promotion response map , activation friction list , outlet-level participation segments, message recall benchmarks, and channel-specific communication priorities, giving commercial teams a clear evidence base for comparing promotion mechanics and timing.
FREQUENTLY ASKED QUESTIONS
Common Questions
Answers to frequently asked questions about this survey mandate.
What decisions will this survey enable?
Who is the buyer vs who are the respondents?
Can we see differences between distributors, stockists and pharmacists?
How will you measure pharma channel preference beyond simple ratings?
Will the survey map the full pharma channel journey and drop-offs?
Can this survey inform product and pricing strategy?
How will findings improve our pharmaceutical channel activation strategy?
Still have questions?
Schedule a discovery call to discuss your specific needs and get a custom quote.